Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin

Critical Care

Volumn 13, Issue 4, 2009, Pages

  Langouche, Lies ^a   Vander Perre, Sarah ^a   Frystyk, Jan ^b   Flyvbjerg, Allan ^b   Hansen, Troels Krarup ^b   Van den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; LEPTIN; RETINOL BINDING PROTEIN 4; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ACUTE STRESS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT DISEASE; SEPSIS; SEX DIFFERENCE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; LUNG DISEASE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; FEMALE; HUMANS; LEPTIN; LUNG DISEASES; MALE; MIDDLE AGED; RETINOL-BINDING PROTEINS, PLASMA;

EID: 68349094024     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7956     Document Type: Article

References (29)

1. Van Cromphaut SJ Vanhorebeek I Berghe Van den G Glucose metabolism and insulin resistance in sepsis Curr Pharm Des 2008, 14:1887-1899 10.2174/ 138161208784980563 18691100
2. Okamoto Y Kihara S Funahashi T Matsuzawa Y Libby P Adiponectin: A key adipocytokine in metabolic syndrome Clin Sci (Lond) 2006, 110:267-278 16464169
3. Wang C Mao X Wang L Liu M Wetzel MD Guan KL Dong LQ Liu F Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1 J Biol Chem 2007, 282:7991-7996 10.1074/ jbc.M700098200 17244624
4. Graham TE Yang Q Bluher M Hammarstedt A Ciaraldi TP Henry RR Wason CJ Oberbach A Jansson PA Smith U Kahn BB Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects N Engl J Med 2006, 354:2552-2563 10.1056/NEJMoa054862 16775236
5. Yang Q Graham TE Mody N Preitner F Peroni OD Zabolotny JM Kotani K Quadro L Kahn BB Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 2005, 436:356-362 10.1038/nature03711 16034410
6. Kolaczynski JW Nyce MR Considine RV Boden G Nolan JJ Henry R Mudaliar SR Olefsky J Caro JF Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro Diabetes 1996, 45:699-701 10.2337/diabetes.45.5.699 8621027
7. Langouche L Perre Vander S Wouters PJ D'Hoore A Hansen TK Berghe Van den G Effect of intensive insulin therapy on insulin sensitivity in the critically ill J Clin Endocrinol Metab 2007, 92:3890-3897 10.1210/ jc.2007-0813 17666481
8. Berghe Van den G Wilmer A Hermans G Meersseman W Wouters PJ Milants I Van Wijngaerden E Bobbaers H Bouillon R Intensive insulin therapy in the medical ICU N Engl J Med 2006, 354:449-461 10.1056/NEJMoa052521 16452557
9. Moody BJ Changes in the serum concentrations of thyroxine-binding prealbumin and retinol-binding protein following burn injury Clin Chim Acta 1982, 118:87-92 10.1016/0009-8981(82)90229-7 6797761
10. Jeevanandam M Begay CK Petersen SR Plasma leptin levels in trauma patients: Effect of adjuvant recombinant human growth hormone in intravenously fed multiple trauma patients JPEN J Parenter Enteral Nutr 1998, 22:340-346 10.1177/0148607198022006340 9829605
11. Tsuchihashi H Yamamoto H Maeda K Ugi S Mori T Shimizu T Endo Y Hanasawa K Tani T Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein: Decrease in rats with polymicrobial sepsis J Surg Res 2006, 134:348-353 10.1016/ j.jss.2006.01.001 16488436
12. Boden G Chen X Mozzoli M Ryan I Effect of fasting on serum leptin in normal human subjects J Clin Endocrinol Metab 1996, 81:3419-3423 10.1210/ jc.81.9.3419 8784108
13. Vitkova M Klimcakova E Kovacikova M Valle C Moro C Polak J Hanacek J Capel F Viguerie N Richterova B Bajzova M Hejnova J Stich V Langin D Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity J Clin Endocrinol Metab 2007, 92:2330-2335 10.1210/ jc.2006-2668 17405846
14. Yang WS Lee WJ Funahashi T Tanaka S Matsuzawa Y Chao CL Chen CL Tai TY Chuang LM Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J Clin Endocrinol Metab 2001, 86:3815-3819 10.1210/jc.86.8.3815 11502817
15. Wajchenberg BL Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome Endocr Rev 2000, 21:697-738 10.1210/ er.21.6.697 11133069
16. Schulze MB Rimm EB Shai I Rifai N Hu FB Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes Diabetes Care 2004, 27:1680-1687 10.2337/ diacare.27.7.1680 15220246
17. Mantzoros CS Li T Manson JE Meigs JB Hu FB Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes J Clin Endocrinol Metab 2005, 90:4542-4548 10.1210/jc.2005-0372 15914524
18. Wu X Thomas SJ Herndon DN Sanford AP Wolf SE Insulin decreases hepatic acute phase protein levels in severely burned children Surgery 2004, 135:196-202 10.1016/j.surg.2003.08.018 14739855
19. Janke J Engeli S Boschmann M Adams F Bohnke J Luft FC Sharma AM Jordan J Retinol-binding protein 4 in human obesity Diabetes 2006, 55:2805-2810 10.2337/db06-0616 17003346
20. Promintzer M Krebs M Todoric J Luger A Bischof MG Nowotny P Wagner O Esterbauer H Anderwald C Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor J Clin Endocrinol Metab 2007, 92:4306-4312 10.1210/jc.2006-2522 17726077
21. Bernard AM Vyskocil AA Mahieu P Lauwerys RR Assessment of urinary retinol-binding protein as an index of proximal tubular injury Clin Chem 1987, 33:775-779 3297418
22. Berghe Van den G Wouters P Weekers F Verwaest C Bruyninckx F Schetz M Vlasselaers D Ferdinande P Lauwers P Bouillon R Intensive insulin therapy in critically ill patients N Engl J Med 2001, 345:1359-1367 10.1056/NEJMoa011300 11794168
23. Carlson GL Saeed M Little RA Irving MH Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis Am J Physiol 1999, 276:E658-E662 10198301
24. Langouche L Meersseman W Perre Vander S Milants I Wouters PJ Hermans G Gjedsted J Hansen TK Arnout J Wilmer A Schetz M Berghe Van den G Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients Crit Care Med 2008, 36:1475-1480 10.1097/ CCM.0b013e31816f7bae 18434900
25. Chen K Li F Li J Cai H Strom S Bisello A Kelley DE Friedman-Einat M Skibinski GA McCrory MA Szalai AJ Zhao AZ Induction of leptin resistance through direct interaction of C-reactive protein with leptin Nat Med 2006, 12:425-432 10.1038/nm1372 16582918
26. Bornstein SR Preas HL Chrousos GP Suffredini AF Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans J Infect Dis 1998, 178:887-890 10.1086/515349 9728566
27. Tzanela M Orfanos SE Tsirantonaki M Kotanidou A Sotiropoulou C Christophoraki M Vassiliadi D Thalassinos NC Roussos C Leptin alterations in the course of sepsis in humans In Vivo 2006, 20:565-570 16900791
28. Arnalich F Lopez J Codoceo R Jim M Madero R Montiel C Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock J Infect Dis 1999, 180:908-911 10.1086/314963 10438392
29. Bone RC Balk RA Cerra FB Dellinger RP Fein AM Knaus WA Schein RM Sibbald WJ Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Chest 1992, 101:1644-1655 10.1378/chest.101.6.1644 1303622